| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| DMK PHARMACEUTICALS Corp | CEO, Director | Common Stock | 906,394 | $547,099 | $0.6036 | 15 Sep 2023 | By Versi Group LLC |
| DMK PHARMACEUTICALS Corp | CEO, Director | Common Stock | 8,745 | $5,278 | $0.6036 | 15 Sep 2023 | Direct |
| Adamis Pharmaceuticals Corp | CEO, Director | Employee Stock Option (Right to Buy) | 20,577 | 25 May 2023 | Direct | ||
| DMK PHARMACEUTICALS Corp | CEO, Director | Series E Convertible Preferred Stock | 1,212 | 15 Sep 2023 | By Versi Group LLC |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000138713123011359-versi-ebrahim-2023-09-15 | DMK PHARMACEUTICALS Corp | 15 Sep 2023 | 2 | $0 | 4 | CEO, Director | 19 Sep 2023, 18:17 |
| /report/000183988223013976-versi-ebrahim-2023-05-25 | Adamis Pharmaceuticals Corp | 25 May 2023 | 8 | $0 | 4 | CEO, Director | 30 May 2023, 18:16 |
| /report/000183988223013972-versi-ebrahim-2023-05-25 | Adamis Pharmaceuticals Corp | 25 May 2023 | 0 | $0 | 3 | CEO, Director | 30 May 2023, 18:11 |